As of 2026-03-16, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 19.7x | 16.8x |
| Forward P/E multiples | 19.8x - 25.5x | 21.9x |
| Fair Price | (3.71) - (3.69) | (3.58) |
| Upside | -111.9% - -111.8% | -111.5% |
| Date | EV/EBITDA |